Actieve functies van Gordon Brooks
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARMO BIOSCIENCES INC | Directeur/Bestuurslid | 21-06-2018 | - |
| DERMIRA, INC. | Directeur/Bestuurslid | 20-02-2020 | - |
| SIGILON THERAPEUTICS, INC. | Directeur/Bestuurslid | 11-08-2023 | - |
Loopbaan van Gordon Brooks
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Director/Board Member | 3 |
Sectoraal
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology ARMO BioSciences, Inc. develops immunotherapy for the treatment of cancer, cardiovascular diseases, fibrosis, and inflammation. Its lead product candidate is AM0010 (pegilodecaki). The company was founded by Peter Van Vlasselaer, Martin Oft, and John B. Mumm on June 23, 2010 and is headquartered in Redwood, CA. | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
- Beurs
- Insiders
- Gordon Brooks
- Ervaring